Banco de Valores S.A. (BCBA:VALO)

Theseus Pharmaceuticals Balance Sheet

Financials in millions ARS. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	175,865	58,482	32,295	29,397	18,891	13,392
Investment Securities	587,152	498,256	110,305	106,099	203,387	48,122
Trading Asset Securities	47,750	988.24	1,404,341	15.78	-	-
Total Investments	634,902	499,244	1,514,646	106,115	203,387	48,122
Gross Loans	429,731	322,758	119,267	4,764	6,168	2,197
Allowance for Loan Losses	-1,876	-2,230	-834.75	-70.19	-58.64	-39.12
Other Adjustments to Gross Loans	-111,228	-105,720	-90,582	-	-	-
Net Loans	316,627	214,808	27,851	4,694	6,110	2,158
Property, Plant & Equipment	10,401	8,744	8,738	1,362	1,520	824.62
Goodwill	50,787	401.1	401.1	-	-	-
Other Intangible Assets	96.51	84.15	148.24	27.66	70.89	72.51
Other Receivables	43,974	5,501	8,139	25.05	38.89	30.82
Restricted Cash	248,964	495,482	679,280	52,704	64,663	39,947
Other Current Assets	2,115	1,494	923.56	237.96	1,302	112.66
Long-Term Deferred Tax Assets	217	4,885	3,053	-	533.91	359.54
Other Long-Term Assets	56,241	36,866	59,128	4,726	8,599	1,646
Total Assets	1,540,190	1,325,991	2,334,603	199,288	305,115	106,665
Accrued Expenses	11,557	10,650	19,286	1,768	1,753	752.76
Interest Bearing Deposits	1,076,101	1,126,312	2,139,988	174,885	281,781	95,509
Total Deposits	1,076,101	1,126,312	2,139,988	174,885	281,781	95,509
Short-Term Borrowings	9,546	0.03	0.05	354.04	703.04	0.17
Current Portion of Leases	195.28	212.97	59.97	12.01	27.01	3.9
Current Income Taxes Payable	3,816	4,018	16,213	154.93	343.52	724.85
Other Current Liabilities	189,787	43,523	18,136	1,552	50.34	77.68
Long-Term Deferred Tax Liabilities	-	-	-	398.91	-	-
Other Long-Term Liabilities	3,631	4,225	1,362	191.95	451.37	148.21
Total Liabilities	1,326,990	1,188,941	2,195,046	179,317	285,110	97,216
Common Stock	996.99	837.44	837.55	836.02	813.83	813.83
Retained Earnings	134,396	111,710	111,385	16,518	16,796	7,791
Comprehensive Income & Other	77,032	23,749	25,970	2,617	2,394	844.35
Total Common Equity	212,425	136,296	138,192	19,971	20,005	9,449
Minority Interest	775.44	754.22	1,365	0.46	0.89	-
Shareholders' Equity	213,200	137,050	139,557	19,971	20,005	9,449
Total Liabilities & Equity	1,540,190	1,325,991	2,334,603	199,288	305,115	106,665
Total Debt	42,097	212.99	60.03	366.05	730.06	4.07
Net Cash (Debt)	195,349	70,855	1,438,569	33,561	200,354	54,125
Net Cash Growth	-68.37%	-95.08%	4186.37%	-83.25%	270.17%	285.74%
Net Cash Per Share	222.66	84.60	1719.16	40.14	246.19	66.51
Filing Date Shares Outstanding	996.99	837.43	866.12	836.02	813.83	813.83
Total Common Shares Outstanding	996.99	837.43	866.12	836.02	813.83	813.83
Book Value Per Share	213.07	162.75	159.55	23.89	24.58	11.61
Tangible Book Value	161,541	135,811	137,643	19,943	19,934	9,376
Tangible Book Value Per Share	162.03	162.17	158.92	23.85	24.49	11.52

Updated Mar 7, 2024. Source: S&P Global Market Intelligence. Banks template. Financial Sources.